Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Endrenyi

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Journal of Biopharmaceutical Statistics|March 1, 1997
Some issues for the consideration of individual bioequivalenceL Endrenyi
International Journal of Clinical Pharmacology and Therapeutics|September 1, 1994
A method for the evaluation of individual bioequivalenceL Endrenyi
Metabolism: Clinical and Experimental|September 1, 1978
Mechanism and significance of carbohydrate intolerance in chronic alcoholismG Sereny, L Endrenyi
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1992
A computationally efficient approach for the design of population pharmacokinetic studiesJ Wang, L Endrenyi
Journal of Biopharmaceutical Statistics|March 1, 1997
Variation of the peak concentration following single and repeated drug administrations in investigations of bioavailability and bioequivalenceJ Zha, L Endrenyi
International Journal of Clinical Pharmacology and Therapeutics|September 3, 1998
Asymmetry of the mean-variability tradeoff raises questions about the model in investigations of individual bioequivalenceL Endrenyi, Y Hao
FEBS Letters|August 25, 1974
New linear plots for the separate estimation of Michaelis-Menten parametersC Fajszi, L Endrenyi
International Journal of Clinical Pharmacology and Therapeutics|April 1, 1997
Truncated AUC evaluates effectively the bioequivalence of drugs with long half-livesL Endrenyi, L Tothfalusi
Canadian Medical Association Journal|November 17, 1973
Relative bioavailability of commercial ampicillin formulations in manM Mayersohn, L Endrenyi
International Journal of Clinical Pharmacology and Therapeutics|May 3, 2001
Evaluation of some properties of individual bioequivalence (IBE) from replicate-design studiesL Tothfalusi, L Endrenyi
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Journal of Biopharmaceutical Statistics|March 1, 1997
Some issues for the consideration of individual bioequivalenceL Endrenyi
International Journal of Clinical Pharmacology and Therapeutics|September 1, 1994
A method for the evaluation of individual bioequivalenceL Endrenyi
Metabolism: Clinical and Experimental|September 1, 1978
Mechanism and significance of carbohydrate intolerance in chronic alcoholismG Sereny, L Endrenyi
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1992
A computationally efficient approach for the design of population pharmacokinetic studiesJ Wang, L Endrenyi
Journal of Biopharmaceutical Statistics|March 1, 1997
Variation of the peak concentration following single and repeated drug administrations in investigations of bioavailability and bioequivalenceJ Zha, L Endrenyi
International Journal of Clinical Pharmacology and Therapeutics|September 3, 1998
Asymmetry of the mean-variability tradeoff raises questions about the model in investigations of individual bioequivalenceL Endrenyi, Y Hao
FEBS Letters|August 25, 1974
New linear plots for the separate estimation of Michaelis-Menten parametersC Fajszi, L Endrenyi
International Journal of Clinical Pharmacology and Therapeutics|April 1, 1997
Truncated AUC evaluates effectively the bioequivalence of drugs with long half-livesL Endrenyi, L Tothfalusi
Canadian Medical Association Journal|November 17, 1973
Relative bioavailability of commercial ampicillin formulations in manM Mayersohn, L Endrenyi
International Journal of Clinical Pharmacology and Therapeutics|May 3, 2001
Evaluation of some properties of individual bioequivalence (IBE) from replicate-design studiesL Tothfalusi, L Endrenyi
Pageof 9